Collegium Pharmaceutical Inc (COLL)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	169,895	193,472	203,646	191,808	166,961	74,953	50,407	25,884	-8,754	-12,556	-18,874	-13,575	17,628	66,746	72,223	72,363	56,232	38,863	12,862	-8,695
Revenue (ttm)	US$ in thousands	631,449	599,245	576,653	566,923	566,767	546,642	536,946	524,949	463,933	361,675	313,505	272,898	276,868	325,777	326,110	321,226	310,016	307,948	301,714	298,696
Operating profit margin		26.91%	32.29%	35.32%	33.83%	29.46%	13.71%	9.39%	4.93%	-1.89%	-3.47%	-6.02%	-4.97%	6.37%	20.49%	22.15%	22.53%	18.14%	12.62%	4.26%	-2.91%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $169,895K ÷ $631,449K
= 26.91%

The operating profit margin of Collegium Pharmaceutical Inc has shown fluctuations over the periods presented. From March 2020 to December 2021, the company experienced a general upward trend in its operating profit margin, peaking at 22.53% in March 2021. However, the margin significantly decreased to 6.37% by the end of December 2021.

Subsequently, the operating profit margin fluctuated between negative figures and positive but lower percentages between March 2022 and December 2022. From March 2023 onwards, there was a notable increase in the operating profit margin, reaching its peak at 35.32% in June 2024. The margin slightly decreased to 26.91% by the end of December 2024.

Overall, Collegium Pharmaceutical Inc has shown a mixed performance in terms of its operating profit margin, with periods of both growth and decline. Investors and stakeholders should continue to monitor the company's future financial results to assess its profitability and financial health.